$MBRX News Article - Moleculin Announces Dosing of
Post# of 62
(Total Views: 146)
Posted On: 03/01/2023 2:15:46 PM
$MBRX News Article - Moleculin Announces Dosing of First Subject in Italy for Phase 1/2 Trial Evaluating Annamycin in Combination with Cytarabine (Ara-C) for the Treatment of Acute Myeloid Leukemia (AML) https://marketwirenews.com/news-releases/mole...17098.html
(0)
(0)Moleculin Biotech, Inc. (MBRX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼